Nuzenio

Expands Conjugate Platform

Expands Conjugate Platform news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 6 latest news signals 6 publisher sources 100/100 entity strength

Latest news

Regeneron Expands Conjugate Platform Strategy Through Parabilis Medicines Collaboration - BioPharm InternationalBioPharm International · Fri, 07 Aug 2026 19:52:06 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -citybuzz - · Fri, 07 Aug 2026 00:22:56 GMTVeraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms - Stock TitanStock Titan · Fri, 31 Jul 2026 07:00:00 GMTAbCellera expands multispecific T-cell engager licensing with USD 28m Vertex deal for autoimmune disease - AllSciAllSci · Wed, 29 Jul 2026 07:00:00 GMTJohnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation - Business WireBusiness Wire · Wed, 29 Jul 2026 07:00:00 GMTVERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms - NewMediaWireNewMediaWire · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Fri, 07 Aug 2026 19:52:06 GMTRegeneron Expands Conjugate Platform Strategy Through Parabilis Medicines Collaboration - BioPharm International
Fri, 07 Aug 2026 00:22:56 GMTVERAXA Biotech Advances VXA-222 bsADC Program and Expands Patent Portfolio - citybuzz -
Fri, 31 Jul 2026 07:00:00 GMTVeraxa Biotech (VRXA) grows patent estate for BiTAC cancer platforms - Stock Titan
Wed, 29 Jul 2026 07:00:00 GMTAbCellera expands multispecific T-cell engager licensing with USD 28m Vertex deal for autoimmune disease - AllSci
Wed, 29 Jul 2026 07:00:00 GMTJohnson & Johnson Completes Acquisition of Firefly Bio, Inc. to Advance Next-Generation Oncology Innovation - Business Wire
Wed, 29 Jul 2026 07:00:00 GMTVERAXA Biotech (VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms - NewMediaWire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Expands Conjugate Platform.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.